ANG:JSEAnglogold Ashanti PLC Analysis
Data as of 2026-05-27 - not real-time
ZAC 153,576.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
AngloGold Ashanti (ANG.JO) trades at ZAc 153,576, sitting just below its 20‑day SMA of ZAc 158,607 and marginally under the 50‑day SMA, indicating a modest short‑term weakness. The RSI of 44.7 suggests the stock is neither oversold nor overbought, while the MACD line remains bearish, reinforcing a cautious near‑term outlook. Volatility remains high at 53% over the past 30 days and beta is low (≈0.43), implying the share moves sharply but is less correlated with the broader market. Fundamentals are robust: revenue surged 65% YoY, operating margin exceeds 56%, and free cash flow hit a record level in Q1, supporting the 5.0% dividend yield and a sustainable payout ratio of roughly 52%. However, the discounted‑cash‑flow fair value of ZAc 25,246 is far below the current price, flagging the stock as significantly overvalued in the short run. Recent Q1 earnings news highlighted the record free cash flow, while the AGM disclosures did not introduce material strategic shifts. Overall, the stock presents strong cash generation and dividend appeal but faces pricing pressure and a neutral technical stance.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD and decreasing volume signal limited upside
- Price near support level (ZAc 146,069) with limited technical momentum
- High short‑term volatility may trigger price swings
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Strong revenue growth (65% YoY) and high operating margins
- Sustainable dividend yield supported by record free cash flow
- Overvaluation relative to DCF fair value tempers enthusiasm
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust cash generation and a 5% dividend yield provide income stability
- High ROE (≈43%) and solid balance sheet with manageable debt
- Long‑term gold price upside potential offsets current pricing premium
Key Metrics & Analysis
Financial Health
Revenue Growth64.90%
Profit Margin31.11%
P/E Ratio13.8
ROE42.97%
ROA22.83%
Debt/Equity22.03
P/B Ratio5.6
Op. Cash FlowZAC5.8B
Free Cash FlowZAC3.6B
Technical Analysis
TrendNeutral
RSI44.7
SupportZAC 146,069.00
ResistanceZAC 182,499.00
MA 20ZAC 158,607.50
MA 50ZAC 161,503.54
MA 200ZAC 144,109.19
MACDBearish
VolumeDecreasing
Fear & Greed Index91.13
Valuation
Fair ValueZAC 25,246.34
Target PriceZAC 191,573.64
Upside/Downside24.74%
GradeOvervalued
TypeBlend
Dividend Yield5.01%
Risk Assessment
Beta0.43
Volatility53.09%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.